MORGAN MARTIN: Open Payments
NPI 1881339216 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 36 payments from 14 companies in 2025. Trend: 2023 $1,080 · 2024 $1,166 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $84 |
| Blueprint Medicines Corporation | 2 | $56 |
| Lilly USA, LLC | 3 | $55 |
| Indivior Inc. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Exact Sciences Corporation | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $36 |
| GENZYME CORPORATION | 1 | $35 |
| UCB, Inc. | 1 | $31 |
Products named: UBRELVY, AYVAKIT, CAPLYTA, QULIPTA, SUBLOCADE, Kerendia, VRAYLAR, MOUNJARO.
Industry payments across FL — which companies pay providers there.
